Investing RAD receives IND approval from US FDA for Betabart (RV-01) July 28, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Asara raises $25m to accelerate exploration at Kada July 28, 2025 Next Post S&P 500 Breaking Out Again: What This Means for Your Portfolio July 28, 2025 Related Posts Morocco, Emmerson Advance Toward US$2.2 Billion Arbitration Over Halted Potash Project August 21, 2025 West High YieldResources Ltd. Welcomes Final EAO Decision on Record Ridge Magnesium Project August 21, 2025 Stallion Uranium Completes First Tranche of Non-Brokered Private Placement and Announces Upsizing August 21, 2025
Morocco, Emmerson Advance Toward US$2.2 Billion Arbitration Over Halted Potash Project August 21, 2025
West High YieldResources Ltd. Welcomes Final EAO Decision on Record Ridge Magnesium Project August 21, 2025
Stallion Uranium Completes First Tranche of Non-Brokered Private Placement and Announces Upsizing August 21, 2025
